| Literature DB >> 32997381 |
Amoura M Abou-El-Naga1, Salwa M Abo El-Khair2, Ashraf Z Mahmoud3, Mohamed Hamza1, Rami M Elshazli4.
Abstract
Limited information has been offered regarding the association of mesothelin (MSLN) gene variants at the 3'-untranslated region with the risk of ovarian carcinoma. The primary objective of this work is to assess the impact of the MSLN (rs1057147 and rs57272256) variants on the progression of ovarian carcinoma among Egyptian women. The study was conceived based on 127 women diagnosed with ovarian carcinoma and 106 unrelated cancer-free controls. Genomic DNA of these MSLN variants was genotyped utilizing the PCR technique. The frequencies of the MSLN (rs1057147) variant revealed a significant association with increased risk of ovarian carcinoma under allelic and dominant models (P < .05). Nonetheless, ovarian cancer patients with the MSLN (rs57272256) variant did not attain considerable significance under all genetic models (P > .05). Together, our findings suggested that the MSLN (rs1057147) variant was associated with an increased risk of ovarian carcinoma, but not the MSLN (rs57272256) variant.Entities:
Keywords: MSLN; genetic variants and ovarian carcinoma; rs1057147; rs57272256
Mesh:
Substances:
Year: 2020 PMID: 32997381 DOI: 10.1002/jbt.22637
Source DB: PubMed Journal: J Biochem Mol Toxicol ISSN: 1095-6670 Impact factor: 3.642